Effect of umbelliferone β-D-galactopyranoside (UFG) on liver in different groups of rat: (A) Normal control: Normal control group Shown normal histopathology (B) Diabetic control: In histopathology of diabetic control group rat shown overblown of micro droplet of fat (yellow arrow indicate) (C) UFG I (10 mg/kg): Histopathology of UFG dose (10 mg/kg) shown deposition of some micro droplet of fat (yellow arrow). (D) UFG II (20 mg/kg): In the histopathology of dose UFG (20 mg/kg) showed few micro droplet deposition of fat (yellow arrow). (E) UFG III (40 mg/kg): Histopathology of UFG (40 mg/kg) drug not showing any fat deposition and other changes. (F) Glibenclamide (10 mg/kg): Histopathology of glibenclamide treated drug group shown similar to the normal control groups. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were examined and 80 pictures were taken. The above picture for each group was chosen randomly from the 80 pictures in this group. Original magnification, 40 × .